Loading…
Jefferies downgraded Evonik to Hold from Buy on November 11, 2026, and cut its 2027 EBITDA forecast by 9 percent to below 2 billion euros. The brokerage said the earnings boost from Middle East supply disruptions is fading, and methionine prices have fallen 43 percent from their April peak in China, 31 percent in Europe and 15 percent in the United States.
Evonik shares traded at 20.94 euros on November 12.
Methionine is a key feed amino acid, so its falling prices from the post-Hormuz peak point to easing costs for feed makers. The downgrade signals that the supply-driven price support is fading.
ad-hoc-news.deRafael MüllerNov 12, 2026Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.
